Evidence map›Paper›PMID 23797537›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2013

Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus.

Xinguo Jiang, Joe L Hsu, Wen Tian, Ke Yuan, Mark Olcholski, Vinicio de Jesus Perez, Gregg L Semenza, Mark R Nicolls

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 27 citations in OpenAlex.

  1. Hyperbaric oxygen therapy to prevent central airway stenosis after lung transplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Airway hypoxia in lung transplantation.Current opinion in physiology · 2019
    Article
  7. Review
  8. Hypoxia Signaling in Vascular Homeostasis.Physiology (Bethesda, Md.) · 2018
    Review
  9. Article
  10. HIF-1alpha and infectious diseases: a new frontier for the development of new therapies.Revista do Instituto de Medicina Tropical de Sao Paulo · 2017
    Review
  11. Review
  12. Review
  13. Review
  14. Microvascular injury after lung transplantation.Current opinion in organ transplantation · 2016
    Review
  15. Hypoxic Gene Expression of Donor Bronchi Linked to Airway Complications after Lung Transplantation.American journal of respiratory and critical care medicine · 2016
    Article
  16. Review
  17. Kidney injury is independent of endothelial HIF-1α.Journal of molecular medicine (Berlin, Germany) · 2015
    Article
  18. Review
  19. Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2015
    Article
  20. Graft microvascular disease in solid organ transplantation.Journal of molecular medicine (Berlin, Germany) · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xinguo JiangMedical Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Joe L Hsu
Wen Tian
Ke Yuan
Mark Olcholski
Vinicio de Jesus Perez
Gregg L Semenza
Mark R Nicolls
Stanford University · USJohns Hopkins University · USVA Palo Alto Health Care System · US

Funding

The Cellular Response to Elafin in PAHP01HL108797 · NHLBI · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2011 to 2021
$19.7M
Critical Role for Microvasculature in Airway TransplantationR01HL095686 · NHLBI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI NICOLLS, MARK ROBERT · 2010 to 2022
$4.7M
BLRD VA I01 BX000509NHLBI NIH HHS HL095686NHLBI NIH HHS P01 HL108797NHLBI NIH HHS R01 HL095686
6 · The paper itself

Abstract

Microvascular ischemia and infections are associated with the development of chronic rejection following lung transplantation. The von Hippel–Lindau protein (VHL) controls protein levels of hypoxia-inducible factors (HIFs), regulates vascular repair, and improves tissue perfusion. Here, we studied the role of VHL in microvascular repair by orthotopically transplanting tracheas into mice with VHL haplodeficiency in Tie2 lineage cells. We showed that VHL haplodeficiency prolonged airway microvascular perfusion and promoted tissue blood flow through the production of the angiogenic factors, SDF-1 and angiopoietin 1. VHL-haplodeficient pulmonary endothelial cells exhibited increased angiogenic activity, resistance to serum deprivation-induced cell death, and enhanced microvascular repair. By contrast, in recipient mice with HIF-1α deficiency in Tie2 lineage cells, microvascular repair was significantly diminished and suggested that recipient-derived HIF-1α normally participates in the repair of alloimmune-mediated microvascular damage. To evaluate the translational impact of our findings, we compared VHL-haplodeficient mice with wild-type controls using a model of Aspergillus airway infection. In 83% of the VHL-haplodeficient recipients, Aspergillus fumigatus was noninvasive in contrast to 75% of wild-type mice in which the mold was deeply invasive. Our study demonstrated that stabilization of HIF-1α in angiogenic cells, through Tie2 cell VHL haplodeficiency, promoted airway microvascular regeneration and vascular normalization and thereby minimized tissue ischemia and hypoxia. By also mitigating the virulence of A. fumigatus, a common pathogen and itself a risk factor for the development of lung transplant rejection, the selective enhancement of HIF-1α expression has the prospect of offering several novel therapeutic effects to transplant recipients.

Indexed as

AnimalsAspergillosisAspergillus fumigatusCell MovementEndothelial CellsHost-Pathogen InteractionsHypoxia-Inducible Factor 1, alpha SubunitLungMiceMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicMicrovesselsNeovascularization, PhysiologicReceptor, TIE-2Regional Blood FlowHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitReceptor, TIE-2Tek protein, mouseVHL protein, mouseVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID23797537
PMCPMC3761091
OpenAlexW2006763417

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.